Penile cancer: Clinical Practice Guidelines in Oncology
- PMID: 23667209
- PMCID: PMC4042432
- DOI: 10.6004/jnccn.2013.0075
Penile cancer: Clinical Practice Guidelines in Oncology
Abstract
Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the United States and other developed countries. Although rare, it is associated with significant disfigurement, and only half of the patients survive beyond 5 years. Proper evaluation of both the primary lesion and lymph nodes is critical, because nodal involvement is the most important factor of survival. The NCCN Clinical Practice Guidelines in Oncology for Penile Cancer provide recommendations on the diagnosis and management of this devastating disease based on evidence and expert consensus.
References
-
- Pettaway CA, Lynch D, Jr, Davis D. Tumors of the penis. In: Wein AJ, Kavoussi L, Novick AC, et al., editors. Campbell-Walsh Urology. 9. Philadelphia: Saunders; 2007. pp. 959–992.
-
- Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–236. - PubMed
-
- Pow-Sang MR, Ferreira U, Pow-Sang JM, et al. Epidemiology and natural history of penile cancer. Urology. 2010;76:S2–6. - PubMed
-
- Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int. 2001;88:473–483. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources